Gary Ingenito - 05 Mar 2025 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Med. & Reg. Officer
Signature
/s/ Gary Ingenito
Issuer symbol
CPRX
Transactions as of
05 Mar 2025
Net transactions value
-$4,390,610
Form type
4
Filing time
07 Mar 2025, 17:00:21 UTC
Previous filing
19 Feb 2025
Next filing
15 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $100,585 +44,904 +65% $2.24 113,777 05 Mar 2025 Direct
transaction CPRX Common stock, par value $0.001 per share Sale $991,929 -44,904 -39% $22.09 68,873 05 Mar 2025 Direct F1, F2
transaction CPRX Common stock, par value $0.001 per share Options Exercise $403,415 +180,096 +261% $2.24 248,969 06 Mar 2025 Direct
transaction CPRX Common stock, par value $0.001 per share Sale $3,902,680 -180,096 -72% $21.67 68,873 06 Mar 2025 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -44,904 -4.4% $0.000000 970,378 05 Mar 2025 Common Stock 44,904 $2.24 Direct F4
transaction CPRX Options to purchase common stock Options Exercise $0 -180,096 -19% $0.000000 790,282 06 Mar 2025 Common Stock 180,096 $2.24 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.
F2 Represents a weighted average price for the shares sold. Shares were sold in a range between $22.00 and $22.285 per share.
F3 Represents a weighted average price for the shares sold. Shares were sold in a range between $21.60 and $21.95 per share.
F4 Options vested in three annual tranches beginning on December 19, 2019.